Last reviewed · How we verify
Diagnostic procedures
Diagnostic procedures are clinical or imaging techniques used to identify, visualize, or confirm the presence of disease or medical conditions.
Diagnostic procedures are clinical or imaging techniques used to identify, visualize, or confirm the presence of disease or medical conditions. Used for General diagnostic imaging and clinical assessment across multiple therapeutic areas.
At a glance
| Generic name | Diagnostic procedures |
|---|---|
| Sponsor | Bayer |
| Modality | Small molecule |
| Therapeutic area | Diagnostics |
| Phase | FDA-approved |
Mechanism of action
Diagnostic procedures encompass a broad category of medical tests and imaging modalities—such as radiography, ultrasound, CT, MRI, endoscopy, and laboratory assays—that help clinicians detect abnormalities, confirm diagnoses, or monitor disease progression. These are not therapeutic agents but rather tools that provide clinical information to guide treatment decisions.
Approved indications
- General diagnostic imaging and clinical assessment across multiple therapeutic areas
Common side effects
Key clinical trials
- Assessment of Periprosthetic Bone Mineral Density in Patients Undergoing Total Knee Prosthesis of Different Design (NA)
- Screening and Multiple Intervention on Lung Epidemics (PHASE2)
- Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers (PHASE3)
- Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer (PHASE2)
- Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial (PHASE2)
- Acceptability of Artificial Intelligence in the Diagnosis of Prostate Cancer (NA)
- WEB-BASED FILIAL THERAPY IN PEDIATRIC CANCER (NA)
- Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Diagnostic procedures CI brief — competitive landscape report
- Diagnostic procedures updates RSS · CI watch RSS
- Bayer portfolio CI